Literature DB >> 35252754

An evaluation of risk factors for Staphylococcus aureus colonization in a pre-surgical population.

Serin Edwin Erayil1, Elise Palzer2, Susan Kline1.   

Abstract

Staphylococcus aureus (SA) colonization has significant implications in healthcare-associated infections. Here we describe a prospective study conducted in pre-surgical outpatients, done with the aim of identifying demographic and clinical risk factors for SA colonization. We found younger age to be a potential predictor of SA colonization.
© 2022 The Authors.

Entities:  

Keywords:  MRSA; MSSA; Staphylococcus aureus; colonization

Year:  2022        PMID: 35252754      PMCID: PMC8895606          DOI: 10.1099/acmi.0.000316

Source DB:  PubMed          Journal:  Access Microbiol        ISSN: 2516-8290


Introduction

(SA) causes 15 % of all healthcare-associated infections [1]. It can lead to serious infections like bacteremia and surgical site infections that have significant implications on healthcare costs, length of hospitalizations and mortality. Carriers of SA have been known to have a higher risk of developing SA infections [2]. In this setting, strategies to identify likely carriers would be a step towards decreasing SA infections, by implementing decolonization protocols in identified carriers [1]. In this study, we analysed data collected on a group of pre-surgical outpatients at a university medical centre to identify risk factors that made them more prone to SA colonization. We selected pre-surgical patients as our population of interest as they provide a unique opportunity to intervene with a decolonization protocol before surgery, potentially preventing post-operative wound infections.

Methods

This was a secondary analysis of a prospective study conducted from August 2011 to September 2016. The larger protocol compared SA decolonization protocols. In this analysis we aimed to evaluate risk factors for SA colonization. Participants were enrolled at the University of Minnesota Medical Centre (UMMC) at Minneapolis, Minnesota, USA. Participants were recruited via convenience sampling. Outpatients in the UMMC orthopaedic, urologic, neurologic, colorectal, cardiovascular and general surgery clinics who were to undergo elective surgery were approached by study personnel and offered study participation. Inclusion criteria included: (1) anticipated surgery >/=10 days after enrollment to allow completion of study procedures, (2) age >/=18 years, (3) ability to complete the decolonization protocol pre-operatively as an outpatient and (4) no antibiotic therapy within 7 days prior to the cultures. Exclusion criteria included (1) inability to give informed consent, (2) surgery anticipated within 10 days after the cultures and (3) allergy to mupirocin or chlorhexidine gluconate that were to be used for the decolonization protocol. All participants provided written informed consent prior to study inclusion. Nasal, throat, axillary and perianal swabs were obtained and cultured for SA. Participants whose cultures detected presumptive SA at any site and who met eligibility criteria were included. Swab cultures and antimicrobial susceptibility testing of presumptive SA isolates were done at UMMC Infectious Diseases Diagnostic Laboratory.

Culture methods

Swabs were inoculated onto 5 % sheep blood agar plates with and without colistin/nalidixic acid. Plates were incubated at 35 °C and inspected at 18–24 h, then were held at room temperature and reinspected at 48 h. Suspect colonies were tested for production of catalase (using hydrogen peroxide; if positive, ) and coagulase and/or protein A (using the Staphaurex assay [Remel]; if positive, presumptive SA). Catalase-positive, Staphaurex-negative colonies that resembled SA underwent a tube coagulase test (if positive, presumptive SA). Susceptibility testing of presumptive SA isolates was done using the Vitek 2 instrument (bioMérieux).

Statistical methods

Penalized logistic regression with a Lasso penalty was used as a variable selection tool to identify demographic and clinical risk factors for SA carriage [3]. Lambda was chosen to minimize the test mean squared error across ten-fold cross validation. Confidence intervals were obtained via bootstrapping and predictive performance of the final model was assessed by an ROC (Receiver Operating Characteristic) curve. Variables considered for risk factor analysis included age, sex, race (white or other), ethnicity, BMI, number of roommates, amount of daily assistance required, ability to self-bathe, employment in healthcare, playing a sport, history of skin infections (MSSA, MRSA, other, none), eczema, other chronic skin conditions, diabetes mellitus, foreign implants, current or former cancer diagnosis, radiation therapy, autoimmune disease and use of corticosteroids. All analyses were conducted using R version 3.5.1 [4]. The University of Minnesota Human Subjects Protection Programme approved the study protocol (IRB ID: 1106 M01086).

Results

Cultures were obtained from 427 patients. A total of 127 participants (29.7 %) confirmed positive for SA at one or more body sites. Of these SA carriers, 89 % were colonized with MSSA and 10.2 % with MRSA, one patient with both (Table 1). Overall, 48.6 % identified as female. Mean age of our population was 55 years. Mean BMI was 30.9. Average number of people living with participants was 1.58.
Table 1.

Screening characteristics by any SA carrier status and MRSA carrier status; values presented are mean (SD) or N (%) where indicated

Screening characteristic

Non-SA carriers

SA carriers

MSSA carrier

MRSA carrier

(N=300)

(N=127)

(N=118)

(N=14)

Female

151 (50.3 %)

58 (45.7 %)

54 (45.8 %)

5 (35.7 %)

Age (yrs.)

58.8 (13.4)

54.5 (13.7)

55.7 (13.6)

50.5 (20.5)

BMI

30.1 (6.58)

31.0 (7.42)

30.9 (7.5)

31.9 (8.3)

Race:

 African American

13 (4.3 %)

8 (6.3 %)

6 (5.1 %)

2 (14.3 %)

 American Indian/Alaska Native

0 (0.0 %)

1 (0.8 %)

0 (0.0 %)

1 (7.1 %)

 Asian

5 (1.7 %)

1 (0.8 %)

1 (0.8 %)

0 (0.0 %)

 Hispanic or Latino

2 (0.7 %)

2 (1.6 %)

2 (1.7 %)

0 (0.0 %)

 White

276 (92.0 %)

111 (87.4 %)

105 (89.0 %)

11 (78.6 %)

Hispanic or Latino (Ethnicity Only)

6 (2.0 %)

2 (1.6 %)

2 (1.7 %)

0 (0.0 %)

Type of Surgery:

 General

41 (13.7 %)

21 (16.5 %)

21 (17.8 %)

2 (14.3 %)

 Cardiovascular

2 (0.7 %)

0 (0.0 %)

0 (0.0 %)

0 (0.0 %)

 Neurosurgical

78 (26.0 %)

24 (18.9 %)

19 (16.1 %)

5 (35.7 %)

 Orthopaedic

156 (52.0 %)

74 (58.3 %)

70 (59.3 %)

7 (50.0 %)

 Urological

22 (7.3 %)

8 (6.3 %)

8 (6.8 %)

0 (0.0 %)

 Colorectal

1 (0.3 %)

0 (0.0 %)

0 (0.0 %)

0 (0.0 %)

No. of people living with subject

1.52 (3.09)

1.5 (1.34)

1.45 (1.27)

1.77 (1.79)

Amount of Daily Living Assistance:

 None

285 (95.0 %)

118 (92.9 %)

110 (93.2 %)

12 (85.7 %)

 Some

12 (4.0 %)

7 (5.5 %)

6 (5.1 %)

1 (7.1 %)

 Complete

1 (0.3 %)

1 (0.8 %)

1 (0.8 %)

0 (0.0 %)

Self-bathes

292 (97.3 %)

120 (94.5 %)

112 (94.9 %)

12 (85.7 %)

Healthcare worker

52 (17.3 %)

17 (13.4 %)

15 (12.7 %)

2 (14.3 %)

Previous soft tissue skin infections:

 MSSA

4 (1.3 %)

3 (2.4 %)

2 (1.7 %)

1 (7.1 %)

 MRSA

10 (3.3 %)

6 (4.7 %)

5 (4.2 %)

1 (7.1 %)

 Unknown Staph aureus

6 (2.0 %)

1 (0.8 %)

1 (0.8 %)

0 (0.0 %)

 Other

17 (5.7 %)

8 (6.3 %)

6 (5.1 %)

2 (14.3 %)

 None

264 (88.0 %)

109 (85.8 %)

104 (88.1 %)

9 (64.3 %)

Previous non-soft tissue skin infection

1 (0.3 %)

2 (1.6 %)

1 (0.8 %)

1 (7.1 %)

Eczema

20 (6.7 %)

8 (6.3 %)

6 (5.1 %)

2 (14.3 %)

Other Chronic Skin Condition

36 (12.0 %)

13 (10.2 %)

11 (9.3 %)

2 (14.3 %)

Diabetes Mellitus

35 (11.7 %)

17 (13.4 %)

16 (13.6 %)

1 (7.1 %)

Has foreign implants

144 (48.0 %)

58 (45.7 %)

52 (44.1 %)

8 (57.1 %)

Corticosteroids

6 (2.0 %)

5 (3.9 %)

4 (3.4 %)

1 (7.1 %)

Has had radiation therapy

11 (3.7 %)

5 (3.9 %)

5 (4.2 %)

0 (0.0 %)

Autoimmune disease

16 (5.3 %)

9 (7.1 %)

8 (6.8 %)

1 (7.1 %)

Screening characteristics by any SA carrier status and MRSA carrier status; values presented are mean (SD) or N (%) where indicated Screening characteristic Non-SA carriers SA carriers MSSA carrier MRSA carrier (N=300) (N=127) (N=118) (N=14) Female 151 (50.3 %) 58 (45.7 %) 54 (45.8 %) 5 (35.7 %) Age (yrs.) 58.8 (13.4) 54.5 (13.7) 55.7 (13.6) 50.5 (20.5) BMI 30.1 (6.58) 31.0 (7.42) 30.9 (7.5) 31.9 (8.3) Race: African American 13 (4.3 %) 8 (6.3 %) 6 (5.1 %) 2 (14.3 %) American Indian/Alaska Native 0 (0.0 %) 1 (0.8 %) 0 (0.0 %) 1 (7.1 %) Asian 5 (1.7 %) 1 (0.8 %) 1 (0.8 %) 0 (0.0 %) Hispanic or Latino 2 (0.7 %) 2 (1.6 %) 2 (1.7 %) 0 (0.0 %) White 276 (92.0 %) 111 (87.4 %) 105 (89.0 %) 11 (78.6 %) Hispanic or Latino (Ethnicity Only) 6 (2.0 %) 2 (1.6 %) 2 (1.7 %) 0 (0.0 %) Type of Surgery: General 41 (13.7 %) 21 (16.5 %) 21 (17.8 %) 2 (14.3 %) Cardiovascular 2 (0.7 %) 0 (0.0 %) 0 (0.0 %) 0 (0.0 %) Neurosurgical 78 (26.0 %) 24 (18.9 %) 19 (16.1 %) 5 (35.7 %) Orthopaedic 156 (52.0 %) 74 (58.3 %) 70 (59.3 %) 7 (50.0 %) Urological 22 (7.3 %) 8 (6.3 %) 8 (6.8 %) 0 (0.0 %) Colorectal 1 (0.3 %) 0 (0.0 %) 0 (0.0 %) 0 (0.0 %) No. of people living with subject 1.52 (3.09) 1.5 (1.34) 1.45 (1.27) 1.77 (1.79) Amount of Daily Living Assistance: None 285 (95.0 %) 118 (92.9 %) 110 (93.2 %) 12 (85.7 %) Some 12 (4.0 %) 7 (5.5 %) 6 (5.1 %) 1 (7.1 %) Complete 1 (0.3 %) 1 (0.8 %) 1 (0.8 %) 0 (0.0 %) Self-bathes 292 (97.3 %) 120 (94.5 %) 112 (94.9 %) 12 (85.7 %) Healthcare worker 52 (17.3 %) 17 (13.4 %) 15 (12.7 %) 2 (14.3 %) Previous soft tissue skin infections: MSSA 4 (1.3 %) 3 (2.4 %) 2 (1.7 %) 1 (7.1 %) MRSA 10 (3.3 %) 6 (4.7 %) 5 (4.2 %) 1 (7.1 %) Unknown 6 (2.0 %) 1 (0.8 %) 1 (0.8 %) 0 (0.0 %) Other 17 (5.7 %) 8 (6.3 %) 6 (5.1 %) 2 (14.3 %) None 264 (88.0 %) 109 (85.8 %) 104 (88.1 %) 9 (64.3 %) Previous non-soft tissue skin infection 1 (0.3 %) 2 (1.6 %) 1 (0.8 %) 1 (7.1 %) Eczema 20 (6.7 %) 8 (6.3 %) 6 (5.1 %) 2 (14.3 %) Other Chronic Skin Condition 36 (12.0 %) 13 (10.2 %) 11 (9.3 %) 2 (14.3 %) Diabetes Mellitus 35 (11.7 %) 17 (13.4 %) 16 (13.6 %) 1 (7.1 %) Has foreign implants 144 (48.0 %) 58 (45.7 %) 52 (44.1 %) 8 (57.1 %) Corticosteroids 6 (2.0 %) 5 (3.9 %) 4 (3.4 %) 1 (7.1 %) Has had radiation therapy 11 (3.7 %) 5 (3.9 %) 5 (4.2 %) 0 (0.0 %) Autoimmune disease 16 (5.3 %) 9 (7.1 %) 8 (6.8 %) 1 (7.1 %) Age was selected as an important predictor of SA carriage with an odds ratio of 0.986 (95 %CI: 0.985, 0.989), indicating that younger age was associated with a higher risk of SA colonization. Fig. 1 graphically shows the results of our analysis in an ROC curve. Age had a sensitivity and specificity of 58 %. The penalized model selected unadjusted age as an important predictor of SA carriage and this association was found to be statistically significant (P<0.001).
Fig. 1.

ROC curve for Age (in years) and SA carriage.

ROC curve for Age (in years) and SA carriage. Gender, race, ethnicity, number of cohabitants, healthcare work, self-bathing and amount of daily assistance required were not found to be associated with SA colonization. We also did not find any association between SA colonization and past medical history of diabetes mellitus, autoimmune disease, corticosteroid use, previous skin and soft tissue infections, radiation therapy, foreign implants, eczema or other chronic skin conditions (Table 1).

Discussion

Surgical infections have significant morbidity, mortality and cost implications. Studies have shown that preoperative SA decolonization can reduce the rates of SA surgical infections [1]. We aimed to evaluate clinical and demographic risk factors for SA colonization. We found age to be a potential predictor of SA colonization, with indication that younger age may perhaps be associated with a higher risk of SA colonization. This is contrary to what one tends to assume about age and SA colonization: that older individuals are more likely be SA carriers. However, we found that this trend has been described in a remarkable number of previous studies as well [5-16]. Older adults may be at increased risk for infection compared to younger adults, due to an increased frequency of comorbid conditions, as well as age-related immune system changes [17]. They also tend to have invasive infections and outcomes tend to be worse. This likely explains our inclination to assume that older adults are more likely to be colonized as well, which it appears to perhaps not necessarily be the case, based on our and other above findings. There are important limitations to this study. We recruited patients by approaching them during their outpatient surgery clinic visits once they had elective surgeries scheduled. This recruitment method, though convenient, meant we also had patients who declined to participate. Reasons for declining participation included being pressed for time, required additional effort, and being disinclined to participate in the rectal swabs that the protocol required, among others. We therefore do not have information on the non-participants and how similar or different they were to the participants. It is also to be noted that age had a sensitivity and specificity of only 58 % in our study, suggesting that some important explanatory variables were not measured. However, our penalized model selected unadjusted age as an important predictor of SA carriage and this association was found to be statistically significant (P<0.001). Therefore, even with these limitations, we feel this study contributes to the understanding of SA infections and could be suggestive of potential avenues for further research.

Conclusions

In this surgical outpatient population, younger age was found to be a potential predictor of SA colonization, although further studies in larger populations are necessary to ascertain the reliability and validity of this association.
  14 in total

1.  Prevalence of Staphylococcus aureus nasal colonization in the United States, 2001-2002.

Authors:  Matthew J Kuehnert; Deanna Kruszon-Moran; Holly A Hill; Geraldine McQuillan; Sigrid K McAllister; Gregory Fosheim; Linda K McDougal; Jasmine Chaitram; Bette Jensen; Scott K Fridkin; George Killgore; Fred C Tenover
Journal:  J Infect Dis       Date:  2005-12-15       Impact factor: 5.226

2.  Risk factors for Staphylococcus aureus colonization in a presurgical orthopedic population.

Authors:  Suzanne E Kent; Gary B Schneider; Brian L Hollenbeck; Steven C Vlad
Journal:  Am J Infect Control       Date:  2019-03-26       Impact factor: 2.918

3.  Prevalence and risk factors for Staphylococcus aureus colonization in individuals entering maximum-security prisons.

Authors:  D V Mukherjee; C T A Herzig; C Y Jeon; C J Lee; Z L Apa; M Genovese; D Gage; C J Koenigsmann; F D Lowy; E L Larson
Journal:  Epidemiol Infect       Date:  2013-06-28       Impact factor: 2.451

4.  Virulence patterns of Staphylococcus aureus strains from nasopharyngeal colonization.

Authors:  S Deinhardt-Emmer; S Sachse; J Geraci; C Fischer; A Kwetkat; K Dawczynski; L Tuchscherr; B Löffler
Journal:  J Hosp Infect       Date:  2017-12-15       Impact factor: 3.926

5.  Are the risk factors associated with Staphylococcus aureus nasal carriage in patients the same than in healthy volunteers? Data from a cohort of patients scheduled for orthopedic material implantation.

Authors:  Elisabeth Botelho-Nevers; Philippe Berthelot; Paul Oswald Verhoeven; Florence Grattard; Celine Cazorla; Frederic Farizon; Bruno Pozzetto; Frederic Lucht
Journal:  Am J Infect Control       Date:  2014-10       Impact factor: 2.918

6.  Body site Staphylococcus aureus colonization among maintenance hemodialysis patients.

Authors:  Samantha J Eells; Kamyar Kalantar-Zadeh; Michael A Bolaris; Larissa May; Loren G Miller
Journal:  Nephron       Date:  2015-01-22       Impact factor: 2.847

7.  Randomized controlled trial of a self-administered five-day antiseptic bundle versus usual disinfectant soap showers for preoperative eradication of Staphylococcus aureus colonization.

Authors:  Susan E Kline; James D Neaton; Ruth Lynfield; Patricia Ferrieri; Shalini Kulasingam; Kayleigh Dittes; Anita Glennen; Selina Jawahir; Alexander Kaizer; Jeremiah Menk; James R Johnson
Journal:  Infect Control Hosp Epidemiol       Date:  2018-07-24       Impact factor: 3.254

8.  The effect of increasing age on the risk of surgical site infection.

Authors:  Keith S Kaye; Kristine Schmit; Carl Pieper; Richard Sloane; Kathleen F Caughlan; Daniel J Sexton; Kenneth E Schmader
Journal:  J Infect Dis       Date:  2005-02-24       Impact factor: 5.226

9.  Risk Factors for Staphylococcus aureus Nasal Colonization in Joint Arthroplasty Patients.

Authors:  Amanda L Walsh; Adam C Fields; James D Dieterich; Darwin D Chen; Michael J Bronson; Calin S Moucha
Journal:  J Arthroplasty       Date:  2017-12-29       Impact factor: 4.757

10.  Staphylococcus aureus nasopharyngeal carriage in rural and urban northern Vietnam.

Authors:  Kinh Van Nguyen; Tianying Zhang; Bich Ngoc Thi Vu; Trinh Tuyet Dao; Toan Khanh Tran; Diep Ngoc Thi Nguyen; Huong Kieu Thi Tran; Chuc Kim Thi Nguyen; Annette Fox; Peter Horby; Heiman Wertheim
Journal:  Trans R Soc Trop Med Hyg       Date:  2014-09-03       Impact factor: 2.184

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.